
Mantle cell lymphoma (MCL) accounts for approximately 6% of all non-Hodgkin’s lymphomas[1][1] and is characterized by the over-expression of cyclin D1 with cell cycle dysregulation, secondary to the genetic abnormality t(11;14)(q13;q32).[2][2] It often has an aggressive clinical course and is
Male, Immunoglobulin kappa-Chains, Bone Marrow, Humans, Diseases of the blood and blood-forming organs, Female, Lymphocytosis, Lymphoma, Mantle-Cell, RC633-647.5
Male, Immunoglobulin kappa-Chains, Bone Marrow, Humans, Diseases of the blood and blood-forming organs, Female, Lymphocytosis, Lymphoma, Mantle-Cell, RC633-647.5
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 28 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
